Bioscript Limited
Registered name: BIOSCRIPT LIMITED
Part of Sovereign Capital Partners LLP groupBioscript Limited made £1.1m revenue and a £9.3m loss in the year to 30 Sep 2024.
Bioscript Limited’s revenue fell 10% to £1.1m in the year to 30 Sep 2024, with a loss of £9.3m and 13 employees. The company is classified under “activities of other holding companies” and is based in Macclesfield; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Macclesfield, North West
- Age
- 5 yrs · since 2021
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Sep 2022 | 30 Sep 2023 | 30 Sep 2024 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £957k | £1.3m | £1.1m |
| Cost of sales | £36.2k | £33.8k | £583k |
| Gross profit | £921k | £1.2m | £560k |
| Operating profit | −£274k | −£13.3m | −£1.2m |
| Profit before tax | −£4.6m | −£21.5m | −£9.3m |
| Profit after tax | −£4.6m | −£21.5m | −£9.3m |
| Profit (best available) | −£4.6m | −£21.5m | −£9.3m |
| Staff costs | £956k | £1.8m | £1.5m |
| Employees (average) | 7 | 11 | 13 |
| Ratios | |||
| Profit margin | −483.2% | −1689% | −812.4% |
| Gross margin | 96.2% | 97.4% | 49% |
| Revenue per employee | £137k | £116k | £87.9k |
| Profit per employee | −£660k | −£2m | −£714k |
| Growth (year on year) | |||
| Revenue growth | — | ▲33.3% | ▼10.4% |
| Headcount growth | — | ▲57.1% | ▲18.2% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £1.1m | £3.6k | £41.1k |
| Net assets | £3.6m | −£18m | −£26.3m |
| Fixed assets | £69.5m | £59.2m | £63.7m |
| Current assets | £1.9m | £943k | £1.9m |
| Debtors | £756k | £939k | £1.8m |
| Deferred income | £165k | £138k | £295k |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Jun 2025 |
How the business works
- Profit margin
- −812.4%
- Profit ÷ revenue.
- Gross margin
- 49%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £87.9k
- Revenue ÷ average employees.
- Profit per employee
- −£714k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 5575%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 25.8%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 160.2%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£26.3m
- Cash at bank
- ▲1049%
- Now £41.1k
- Headcount
- ▲18%
- Now 13
- Deferred income
- ▲113%
- Now £295k
- Fixed assets
- ▲8%
- Now £63.7m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Sovereign Capital Partners LLPultimate parent75–100%
- BB Shelf 4 LLP75–100%
- Bioscript Holdings Limited75–100%
- Bioscript Midco 1 Limited75–100%
- Bioscript Midco 2 Limited75–100%
- Bioscript Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (6)
- Valid Insight LtdRev. £1.8m · Profit £234k
- Enzyme Communications LtdRev. £1.5m · Profit £362k
- Azimuth Pharma LimitedFigures not disclosed
- Bioscript Group LimitedRev. — · Profit −£10
- Meridian Healthcomms Holdings LimitedRev. — · Profit −£86k
- Triducive Partners LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 30 Sep 2024 (profit −£9.3m), from the Companies House accounts bulk data published Jun 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.